Accommodation in renal transplantation: Unanswered questions

Current Opinion in Organ Transplantation

Volumn 15, Issue 4, 2010, Pages 481-485

  Lynch, Raymond J ^a   Platt, Jeffrey L ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

accommodation; rejection; renal transplant; tolerance

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C4D; HLA ANTIGEN; MELITTIN; STREPTOLYSIN O; ANTIBODY; BLOOD GROUP ABO SYSTEM;

ADULT; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; BLOOD GROUP INCOMPATIBILITY; CASE REPORT; CLINICAL EVALUATION; CORRELATION ANALYSIS; CYTOTOXICITY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GLOMERULOPATHY; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNE MEDIATED INJURY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PLASMAPHERESIS; REVIEW; ANIMAL; BLOOD; BLOOD GROUP ABO SYSTEM; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ANIMALS; ANTIBODIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 77955228420     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32833b9c25     Document Type: Review

References (45)

1. Chopek MW, Simmons RL, Platt JL. ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc 1987; 19:4553-4557.
2. Bannett AD, McAlack RF, Morris M, et al. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 1989; 21:783-785.
3. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11:450-456.
4. Lynch RJ, Platt JL. Escaping from rejection. Transplantation 2009; 88:1233-1266.
5. Rother RP, Arp J, Jiang J, et al. C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients. Am J Transplant 2008; 8:1129-1142.
6. Starzl TE, Marchioro TL, Holmes JH, Waddell WR. The incidence, cause, and significance of immediate and delayed oliguria or anuria after human renal transplantation. Surg Gynecol Obstet 1964; 118:819-827.
7. Alexandre GPJ, Squifflet JP, De Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19:4538-4542.
8. Alexandre GPJ, Squifflet JP, De Bruyere M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985; 17:138-143.
9. Warren DS, Montgomery RA. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange. Immunol Res 2010 [Epub ahead of print].
10. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004; 4:1315-1322.
11. Segev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5:2570-2575.
12. Glotz D, Antoine C, Julia P, et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002; 2:758-760.
13. Angelini A, Castellani C, Poli F, et al. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation. J Heart Lung Transplant 2008; 27:1357-1360.
14. Koch CA, Khalpey ZI, Platt JL. Accommodation: preventing injury in transplantation and disease. J Immunol 2004; 172:5143-5148.
15. Koch CA, Kanazawa A, Nishitai R, et al. Intrinsic resistance of hepatocytes to complement-mediated injury. J Immunol 2005; 174:7302-7309.
16. Tobian AA, Shirey RS, Montgomery RA, et al. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008; 48:2453-2460.
17. Gloor JM, Lager DJ, Fidler ME, et al. A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005; 80:1572-1577.
18. Ishida H, Tanabe K, Ishizuka T, et al. Differences in humoral immunity between a nonrejection group and a rejection group after ABO-incompatible renal transplantation. Transplantation 2006; 81:665-671.
19. Kraus ES, Parekh RS, Oberai P, et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant 2009; 9:1826-1834.
20. Sis B, Mengel M, Haas M, et al. Banff '09 Meeting Report: Antibody-mediated graft deterioration and implementation of Banff Working Groups. Am J Transplant 2010 [Epub ahead of print]
21. Lau CL, Cantu E, Gonzalez-Stawinski GV, et al. The role of antibodies and Von Willebrand factor in discordant pulmonary xenotransplantation. Am J Transplant 2003; 3:1065-1075.
22. Cinti P, Pretagostini R, Lai Q, et al. Alloantibodies and outcomes of deceased donor kidney allografts. Hum Immunol 2009; 70:651-654.
23. Aubert V, Venetz JP, Pantaleo G, Pascual M. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. HumImmunol 2009; 70:580-583.
24. Susal C, Dohler B, Opelz G. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 2009; 70:569-573.
25. Lynch RJ, Platt JL. Accommodation in organ transplantation. Curr Opin Organ Transplant 2008; 13:165-170.
26. Parker W, Lin SS, Platt JL. Antigen expression in xenotransplantation: how low must it go? Transplantation 2001; 71:313-319.
27. Yu PB, Holzknecht ZE, Bruno D, et al. Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol 1996; 157:5163-5168.
28. Dalmasso AP, Benson BA, Johnson JS, et al. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 2000; 164:3764-3773.
29. Ding JW, Zhou T, Ma L, et al. Expression of complement regulatory proteins in accommodated xenografts induced by antialpha-Gal IgG1 in a rat-to-mouse model. Am J Transplant 2007; 7:1-9.
30. Iwasaki K, Miwa Y, Haneda M, et al. Significance of HLA class I antibodyinduced antioxidant gene expression for endothelial cell protection against complement attack. Biochem Biophys Res Commun 2010; 391:1210-1215.
31. Reiter Y, Ciobotariu A, Jones J, et al. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calciumdependent cross-protection from lysis. J Immunol 1995; 155:2203-2210.
32. Grubbs BC, Benson BA, Dalmasso AP. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement. Xenotransplantation 2003; 10:387-397.
33. Griesemer AD, Okumi M, Shimizu A, et al. Upregulation of CD59: potential mechanism of accommodation in a large animal model. Transplantation 2009; 87:1308-1317.
34. Platt JL, Nath KA. Heme oxygenase: protective gene or Trojan horse. Nat Med 1998; 4:1364-1365.
35. Soares MP, Lin Y, Sato K, et al. Accommodation. Immunol Today 1999; 20:434-437.
36. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: Expression of ''protective genes'' by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3:196-204.
37. Dehoux JP, Gianello P. Accommodation and antibodies. Transpl Immunol 2009; 21:106-110.
38. Smith RN, Kawai T, Boskovic S, et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 2008; 8:1662-1672.
39. Kenmochi T, Saigo K, Maruyama M, et al. Results of kidney transplantation from ABO-incompatible living donors in a single institution. Transplant Proc 2008; 40:2289-2291.
40. Oettl T, Halter J, Bachmann A, et al. ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transplant 2009; 24:298-303.
41. Dipchand AI, Pollock Barziv SM, Manlhiot C, et al. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant 2009 [Epub ahead of print].
42. Toki D, Ishida H, Horita S, et al. Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation. Transplantation 2009; 88:1186-1193.
43. Mai ML, Ahsan N, Wadei HM, et al. Excellent renal allograft survival in donorspecific antibody positive transplant patients - role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation 2009; 87:227-232.
44. Thielke JJ, West-Thielke PM, Herren HL, et al. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Transplantation 2009; 87:268-273.
45. Varma PP, Hooda AK, Kumar A, Singh L. Highly successful and low-cost desensitization regime for sensitized living donor renal transplant recipients. Ren Fail 2009; 31:533-537.